RxDoctor Payments Data

John Sloan, MD

Physical Medicine & Rehabilitation · Albuquerque, NMNPI 1922117019

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 47.2% of the total. Among physical medicine & rehabilitation clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,593in general payments, 2019–2025

Across 36 payments — averaging $155.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pacira Pharmaceuticals Incorporated$3K
  • Nevro Corp.$1K
  • Medtronic$565
  • Abbott$421
  • Merz Pharmaceuticals, LLC$164
  • Mimedx Group, Inc.$133
  • plus $266 from 5 others

What the payments were for

  • Speaking & faculty fees$1,18621%
  • Travel & lodging$2,40043%
  • Food & beverage$2,00736%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,593 in reported general payments places this provider in the 90th percentile of 41 physical medicine & rehabilitation providers in New Mexico.

See all physical medicine & rehabilitation providers in New Mexico

Medicare billing

Part B allowed, 2024
$372,385
Medicare patients
580
Services billed
9,309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BotoxOnabotulinumtoxina14$26,431
OxycontinOxycodone Hcl25$14,636
Oxycodone Hcl499$8,955
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen231$5,940
Tizanidine Hcl168$2,464
Fentanyl25$2,238
Naloxone Hcl30$2,048
Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine13$1,963
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen58$1,926
Gabapentin142$1,912
Pregabalin107$1,555
Morphine Sulfate ErMorphine Sulfate30$1,210
Baclofen38$1,122
Duloxetine Hcl70$857
Cyclobenzaprine Hcl52$703

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieBotox$106$26,43114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 41 physical medicine & rehabilitation providers in New Mexico.

Other physical medicine & rehabilitation in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →